Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Isaku Shinzato"'
Publikováno v:
European Journal of Case Reports in Internal Medicine (2021)
Angioimmunoblastic T-cell lymphoma (AITL) can be complicated by Epstein-Barr virus (EBV)-positive B-cell lymphoma. B-cell lymphoma may develop simultaneously at the time of AITL diagnosis or after treatment for AITL. EBV-associated B-cell lymphoma ca
Externí odkaz:
https://doaj.org/article/ce774f55475b42b7b6d8a13669d7e886
Publikováno v:
Clinical Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
Abstract A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic
Externí odkaz:
https://doaj.org/article/1363783f75174ed7b6117e3a91bfbb86
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
Myelodysplastic syndrome (MDS) terminally transforms to acute myeloid leukemia (AML) or bone marrow failure syndrome, but acute myeloid leukemia with basophilic differentiation has been rarely reported. An 81-year-old man was referred to our departme
Externí odkaz:
https://doaj.org/article/bd6c7dc1fb624422af916a4f0f81096c
Publikováno v:
Case Reports in Infectious Diseases, Vol 2015 (2015)
Primary pyomyositis is a bacterial infection of the skeletal muscle commonly affecting children with Staphylococcus aureus most often isolated as a pathogen. However, pyomyositis caused by anaerobic bacteria is rare in adults. Here, we report a case
Externí odkaz:
https://doaj.org/article/2a3725243b0f4ebea02c5f9d163f7250
Publikováno v:
Journal of Medical Cases
Lymphoproliferative disorders (LPDs) occur frequently in patients with rheumatoid arthritis (RA) under methotrexate treatment. Some LPDs spontaneously regressed after methotrexate discontinuation, but classic Hodgkin lymphoma (CHL)-type LPDs frequent
Autor:
Kazuyoshi Ishii, Yoshinori Hashimoto, Aya Nakaya, Yasuhiro Tanaka, Isaku Shinzato, Toshinori Kondo, Takahisa Nakanishi, Shosaku Nomura, Atsushi Satake, Akiko Konishi, Takayuki Tanaka, Akiko Hashimoto, Tomoki Ito, Shinya Fujita, Hideaki Yoshimura, Masaaki Hotta, Hiromi Omura
Publikováno v:
International Journal of Hematology. 112:33-40
Anagrelide is widely used for cytoreductive therapy in patients with essential thrombocythemia who are at high risk for thrombosis. The recommended starting dose in the package insert of anagrelide varies by country. A high starting dose leads to an
Publikováno v:
Eur J Case Rep Intern Med
European Journal of Case Reports in Internal Medicine (2021)
European Journal of Case Reports in Internal Medicine (2021)
Angioimmunoblastic T-cell lymphoma (AITL) can be complicated by Epstein-Barr virus (EBV)-positive B-cell lymphoma. B-cell lymphoma may develop simultaneously at the time of AITL diagnosis or after treatment for AITL. EBV-associated B-cell lymphoma ca
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
Clinical Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effec
Autor:
Kimikazu Yakushijin, Hirotaka Suto, Yu Mizutani, Yoshiharu Miyata, Marika Okuni, Katsuya Yamamoto, Yasuyuki Saito, Keiji Kurata, Isaku Shinzato, Shigeki Nagao, Seiji Kakiuchi, Keiichiro Uehara, Rina Sakai, Hiroya Ichikawa, Yasuhiro Tanaka, Akiko Hashimoto, Mitsuhiro Ito, Yumiko Inui, Hironobu Minami, Hiroshi Matsuoka, Shinichiro Kawamoto
Publikováno v:
Internal Medicine
A 45-year-old woman was diagnosed with hepatosplenic T-cell lymphoma (HSTCL), a rare subtype of peripheral T-cell lymphoma. She received different types of chemotherapy, but disease progression was observed. To reduce the tumor burden before an unrel
Autor:
Yasuhiro Tanaka, Misa Ishihara, Isaku Shinzato, Koichi Ohshima, Akiko Hashimoto, Hiroaki Miyoshi
Publikováno v:
Journal of Clinical and Experimental Hematopathology : JCEH
Diffuse large B cell lymphoma (DLBCL) is classified as an aggressive lymphoma due to its poor prognosis regardless of the treatment. Almost all cases of DLBCL are treated using rituximab-combination chemotherapy, but spontaneous regression without an